Cargando…
Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire
BACKGROUND: Patients with pulmonary arterial hypertension (PAH) and other forms of precapillary pulmonary hypertension (PH) have impaired quality of life (QoL). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is a PH-specific patient-reported outcome measure that assesses symptoms, act...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962538/ https://www.ncbi.nlm.nih.gov/pubmed/27460644 http://dx.doi.org/10.1186/s12955-016-0513-8 |
_version_ | 1782444855871406080 |
---|---|
author | Reis, Abílio Twiss, James Vicente, Margarida Gonçalves, Fabienne Carvalho, Luísa Meireles, José Melo, Alzira McKenna, Stephen P. Almeida, Luís |
author_facet | Reis, Abílio Twiss, James Vicente, Margarida Gonçalves, Fabienne Carvalho, Luísa Meireles, José Melo, Alzira McKenna, Stephen P. Almeida, Luís |
author_sort | Reis, Abílio |
collection | PubMed |
description | BACKGROUND: Patients with pulmonary arterial hypertension (PAH) and other forms of precapillary pulmonary hypertension (PH) have impaired quality of life (QoL). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is a PH-specific patient-reported outcome measure that assesses symptoms, activity limitations and QoL. It was originally developed in UK-English. The main objective of this study was to create an adaptation of the CAMPHOR suitable for a Portuguese-speaking population. METHODS: A multi-step approach was followed: bilingual and lay panel translation; cognitive debriefing interviews; and psychometric testing in repeated postal surveys (2 weeks apart) including assessment of internal consistency, reproducibility and validity. The Nottingham Health Profile (NHP) questionnaire was used as a comparator instrument to test convergent validity. RESULTS: The CAMPHOR was translated without difficulty by the two panels. Cognitive debriefing interviews showed the questionnaire was easily understood and considered relevant to patients’ experience with their illness. Psychometric evaluation was performed with 50 PAH patients (47 ± 14 years, 37 women). Cronbach’s alpha coefficients showed good internal consistency for the three CAMPHOR scales [Symptoms = 0.95; Activities = 0.93 and QoL = 0.94]. Test-retest coefficients showed that all scales had excellent reliability (Symptoms = 0.94; Activities = 0.89 and QoL = 0.93), indicating low levels of random measurement error. The CAMPHOR correlated as expected with the NHP. The magnitude of correlations followed a similar pattern to those in the original development study. The CAMPHOR also exhibited evidence of known group validity in its ability to distinguish between self-reported severity and general health groups. CONCLUSIONS: A valid and reliable version of the CAMPHOR questionnaire for the European Portuguese-speaking population was developed and is recommended for use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0513-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4962538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49625382016-07-28 Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire Reis, Abílio Twiss, James Vicente, Margarida Gonçalves, Fabienne Carvalho, Luísa Meireles, José Melo, Alzira McKenna, Stephen P. Almeida, Luís Health Qual Life Outcomes Research BACKGROUND: Patients with pulmonary arterial hypertension (PAH) and other forms of precapillary pulmonary hypertension (PH) have impaired quality of life (QoL). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is a PH-specific patient-reported outcome measure that assesses symptoms, activity limitations and QoL. It was originally developed in UK-English. The main objective of this study was to create an adaptation of the CAMPHOR suitable for a Portuguese-speaking population. METHODS: A multi-step approach was followed: bilingual and lay panel translation; cognitive debriefing interviews; and psychometric testing in repeated postal surveys (2 weeks apart) including assessment of internal consistency, reproducibility and validity. The Nottingham Health Profile (NHP) questionnaire was used as a comparator instrument to test convergent validity. RESULTS: The CAMPHOR was translated without difficulty by the two panels. Cognitive debriefing interviews showed the questionnaire was easily understood and considered relevant to patients’ experience with their illness. Psychometric evaluation was performed with 50 PAH patients (47 ± 14 years, 37 women). Cronbach’s alpha coefficients showed good internal consistency for the three CAMPHOR scales [Symptoms = 0.95; Activities = 0.93 and QoL = 0.94]. Test-retest coefficients showed that all scales had excellent reliability (Symptoms = 0.94; Activities = 0.89 and QoL = 0.93), indicating low levels of random measurement error. The CAMPHOR correlated as expected with the NHP. The magnitude of correlations followed a similar pattern to those in the original development study. The CAMPHOR also exhibited evidence of known group validity in its ability to distinguish between self-reported severity and general health groups. CONCLUSIONS: A valid and reliable version of the CAMPHOR questionnaire for the European Portuguese-speaking population was developed and is recommended for use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-016-0513-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-26 /pmc/articles/PMC4962538/ /pubmed/27460644 http://dx.doi.org/10.1186/s12955-016-0513-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Reis, Abílio Twiss, James Vicente, Margarida Gonçalves, Fabienne Carvalho, Luísa Meireles, José Melo, Alzira McKenna, Stephen P. Almeida, Luís Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire |
title | Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire |
title_full | Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire |
title_fullStr | Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire |
title_full_unstemmed | Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire |
title_short | Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire |
title_sort | portuguese validation of the cambridge pulmonary hypertension outcome review (camphor) questionnaire |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962538/ https://www.ncbi.nlm.nih.gov/pubmed/27460644 http://dx.doi.org/10.1186/s12955-016-0513-8 |
work_keys_str_mv | AT reisabilio portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT twissjames portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT vicentemargarida portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT goncalvesfabienne portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT carvalholuisa portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT meirelesjose portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT meloalzira portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT mckennastephenp portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire AT almeidaluis portuguesevalidationofthecambridgepulmonaryhypertensionoutcomereviewcamphorquestionnaire |